BSG abstractsand endoscopic investigations performed up to 5 years previously were reviewed. Episodes of negative investigations were considered 'missed' opportunities for diagnosis. Clinical outcomes were compared using chi-squared test and Kaplan-Meier survival curves. Results 396 colorectal cancers were identified with 214 (54%) males and median age 72. Of these, 29 (7%) patients had undergone negative investigations including colonoscopy (n = 8), flexible sigmoidoscopy (n = 7), barium enema (n = 7) and CT for abdominal symptoms (n = 20) ('missed' group) within the previous 5 years, median 817 days prior to diagnosis. Age, mode of presentation, tumour site, pT and pN stage were comparable between groups. Metastases at presentation were more common in the 'missed' group (28% vs. 14%, p = 0.046) and survival at median follow-up of 416 days was significantly reduced (66% vs. 88%, p = 0.0004). Conclusion A small proportion (7%) of patients with colorectal cancer has undergone previous negative abdominal or colonic investigation. Such episodes may represent missed opportunities for diagnosis and survival is significantly reduced in such patients. The recognition that endoscopic and radiological investigations may miss lesions should encourage repeat or alternative interval investigations where concerning symptoms exist. Disclosure of Interest None Declared. Introduction Studies have reported a high prevalence of lower gastrointestinal (LGI) symptoms in bowel cancer screening (BCSP) patients. However, symptoms are often vague and without characterisation their significance is unclear. This study investigates the prevalence and characteristics of lower gastrointestinal symptoms in screening patients and aims to determine the relevance of two week wait (2ww) symptoms in this cohort. Methods A prospective cohort study was performed. BCSP patients presenting for colonoscopy over a 7-month period were included. Data on symptom prevalence, frequency and duration was collected and assessed against 2-week wait criteria. Associations between symptom prevalence and outcome were investigated using the two-tailed χ 2 test. Results Symptom and outcome data was collected in 397 patients.
TWO WEEK WAIT SYMPTOMS ARE PREVALENT IN BOWEL CANCER SCREENING PATIENTS WITH A POSITIVE FAECAL OCCULT BLOOD TEST BUT DO NOT PREDICT CANCERLGI symptoms were reported by 282 (71%) patients and 37 patients (9%) were found to have colorectal cancer (CRC). Symptom prevalence was comparable between those with or without CRC (65% vs.72%, p = 0.473). Meanwhile, 2ww symptoms were reported in 148 (37%) of all patients. 2ww symptom prevalence was comparable in those with and without cancer (38% vs. 39%, p = 0.915). Conclusion This study demonstrates that while 2ww symptoms are highly prevalent in a FOB positive cohort, they do not predict a finding of colorectal cancer. These findings suggest that 2ww symptoms could not be used to prioritise investigation in this cohort while in those patients referred with 2ww symptoms, additional FOB testing would offer ...